A systematic review and meta-analysis of over 140 studies sheds light on which drug classes, including NMDA-receptor antagonists and VGSC blockers, can reduce secondary hyperalgesia.

Current and former employees sold stock to investors, including Thrive Capital, SoftBank, Dragoneer Investment Group, Abu ...

The DARWIN EU links national databases to deliver real-world evidence that supports safer and faster regulatory decisions.

September labor data shows cooling job market and steady unemployment, impacting stocks and yields. Click here to read what ...

Prescott, Arizona / Syndication Cloud / September 20, 2025 / David Bynon Key Takeaways WebMEM, an AI-first publishing ...

The Medicare program effectively reduced insulin costs, improved adherence, and increased plan enrollment, benefiting both ...

HHS has put on ice a CDC project that would make information about dozens of diseases available in near real time, CDC sources told MedPage Today. Since early summer, the team has been working on a ...

A Yale School of Medicine-led research group, working with six US health systems, reports an association between a single ...

OpenAI could now be the world's most valuable startup, ahead of Elon Musk's SpaceX and TikTok's parent company ByteDance, ...

Objective To develop and compare algorithms for identifying gestational diabetes mellitus (GDM) across European electronic ...

Inclusion in major indexes like the Russell 2000/3000 enhances Bitdeer's visibility and credibility. This milestone attracts ...

The FDA is expected to decide on treatments for achondroplasia, acute myeloid leukemia, familial chylomicronemia syndrome, immunoglobulin A nephropathy, and non-small cell lung cancer.